Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
CVS Health Ventures
United States
- Woonsocket, Rhode Island
- 16/11/2022
- Series E
- $90,000,000
CVS Health Ventures is a dedicated corporate venture capital fund that works with high-potential, early-stage companies focused on making health care more accessible, affordable, and simpler.
We invest in and partner with companies with the potential for technology-enabled innovation and disruption in digital health care. Our goal is to enable promising entrepreneurs to scale more quickly and effectively through access to our unmatched enterprise capabilities and consumer touchpoints, while offering expertise and insights from CVS Health's unique perspective.
- Industry Venture Capital and Private Equity Principals
- Website https://www.cvshealth.com/about-cvs-health/ventures
- LinkedIn https://www.linkedin.com/showcase/cvs-health-ventures/
Related People
Karen S. LynchFounder
United States -
Woonsocket, Rhode Island
As President and Chief Executive Officer of CVS Health, I’m focused on supporting individuals during every meaningful moment of health throughout their lifetime.
With a team of more than 300,000 colleagues, I lead CVS Health’s strategy to transform health care to be simpler, more convenient and more personalized. We are working to create a health system that will help you wherever you are – in the community, in the home, and digitally – with solutions that connect and simplify everyday interactions.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)